Get Started FOSTERING COLLABORATIONS BETWEEN NIGERIA'S FINEST RESEARCHERS & INTERNATIONAL COUNTERPARTS FOSTERING COLLABORATIONS Courses PROVIDING SAFETY NET FOR RESEARCH INVESTIGATORS AND PARTICIPANTS Services PROVIDING A SAFETY NET Get Started PROVIDING A WORLD CLASS PLATFORM FOR THE CONDUCT OF RESEARCH AND CLINICAL TRIALS PROVIDING A WORLD CLASS PLATFORM Courses CREATING OPPORTUNTIES FOR CAPACITY BUILDING Services CREATING OPPORTUNTIES

About Us

The International Research Center of Excellence (IRCE) was established in 2015 to create an enabling environment that facilitates research activities that bridge international and Nigerian researchers.

0

Cumulative
Publications

0

Research
Team

0

Current
Researches

What We Do

A creative and systematic work undertaken to increase the stock of knowledge.

A phase of research to describe clinical trials that focus on the safety of a drug

OBJECTIVES

Providing a
World Class Platform

Provide a common world class platform for the implementation of research and clinical trials at international standards as part of global networks

Fostering
Collaborations

We foster collaborations and synergism between Nigeria’s finest researchers and their counterparts at international research institutions and universities

Providing Safety-Net
for Research Implementation

Provide a safety net that protects IHVN and its collaborators from liability by proactively ensuring that research conducted at IHVN is under the highest scientific and ethical standards

Opportunities
to Researchers

We provide opportunities for young Nigerian researchers to develop and execute research projects, being mentored by more experienced investigators at IHVN, Nigerian Universities, the diaspora, and international research institutions and universities.

Fostering
Collaborations

We foster collaborations and synergism between Nigeria’s finest researchers and their counterparts at international research institutions and universities

Providing a Safety-Net
for Research Implementation

 We provide a safety net that protects IHVN and its collaborators from liability by proactively ensuring that research at IHVN is conducted under the highest scientific and ethical standards

Providing a
World Class Platform

Provide a common world class platform for the implementation of research and clinical trials at international standards as part of global networks

LATEST NEWS

  • Newly Funded Research Grant – EXPAND NIGERIA

    Expanding the Pool of Independent Investigators in Implementation Science in Nigeria through HIV Research training (EXPAND NIGERIA) Dr. Nadia Sam-Agudu (Contact PI/Project Leader) and Prof. Alash’le Abimiku (multi-PI) were recently awarded a grant by the National Institutes of Health (NIH) to provide specialized training on implementation science and its use in HIV research and program implementation

    June 2, 2022
  • Newly Funded Research Grant: Evaluation of Point-of-Care (EPOC)

    Title: Evaluation of Point-of-Care (EPOC) Principal Investigator: Dr Eriobu Nnakelu Funding Agency: National Institute of Allergy and Infectious Diseases (NIAID) Amount: $15,000 Duration: 1 Year Proposed Start time: June 2022 Summary: The EPOC study is designed to examine the feasibility of conducting two point-of-care (POC) tests: The LumiraDx SARS-CoV-2 antibody test and the RightSign COVID-19 IgG/IgM

    May 24, 2022
  • IMPACT Study One Day Kick Off Meeting of All Stakeholders

    The International Research Center of Excellence at the Institute of Human Virology Nigeria in collaboration with the African Cancer Registry Network (AFCRN) and The Bloomberg Philanthropies Data for Health Initiative Global Grants Program (GGP) held a Stakeholder Engagement meeting to kick-off the IMPACT study. The study which seeks to improve population level stage at diagnosis

    April 14, 2022
  • TRiAD STUDY 10C MTB/XDR GENE XPERT INSTALLATION AT PLASVIREC PLATEAU & NIMR, LAGOS STATE

    Gene Xpert MTB/XDR machine is a system which assay is a nucleic acid amplification (NAA) base test that simultaneously detect DNA of Mycobacterium tuberculosis complex (MTBC) and resistant to isoniazid (INH), fluoroquinolones (FLQ) Ethionamide (ETH), and second-line injectable drugs (SLID) in unprocessed sputum samples and concentrated sputum sediments in 90 minutes. The Xpert MTB/XDR Assay

    April 11, 2022

IRCE MISSION

Our mission is to foster qualitative research ethics among the systems. 

FOR CAPACITY BUILDINGCREATING ENDLESS OPPORTUNITES

Services

REQUEST A CALL BACK.

Would you like to speak to one of our Team members over the phone? Just submit your details and we’ll be in touch shortly. You can also email us if you would prefer.

    I would like to discuss: